The election is over and no matter how you feel about Obama, he will be the next U.S. president. A sharp increase in new debt could push up interest rates and continue the downward pressure on the stock market. Let's look at some possible winners:

Investors have long enjoyed a love-hate relationship with pharmaceutical stocks. This sector is unique in that their products are effectively scheduled for obsolescence via expiring patents. As such, a pharmaceutical company's pipeline of new products is just as important, or maybe more important, than the company's current offerings.

Stock Analysis of Abbott Laboratories (ABT). The analysis includes a detailed PDF.